Who owns X4 PHARMACEUTICALS INC COM NEW?
- Ticker: XFOR
- CUSIP Number: 98420x202
Tip: Access positions for across all investors
Analyze quarterly positions in X4 Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of X4 Pharmaceuticals stock
Who bought or sold X4 PHARMACEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Empery Asset Management | 9.0M | $36M | 100% | Dec 2025 |
|
| Bain Capital Life Sciences Investors | 8.0M | $32M | 227% | Dec 2025 |
|
| Saturn V Capital Management | 5.8M | $23M | 100% | Dec 2025 |
|
| Deep Track Capital | 5.0M | $20M | 347% | Dec 2025 |
|
| Vanguard Group | 3.4M | $14M | 734% | Dec 2025 |
|
| Braidwell | 3.4M | $14M | 100% | Dec 2025 |
|
| Rosalind Advisors | 2.6M | $10M | 69% | Dec 2025 |
|
| Nantahala Capital Management | 2.4M | $9.8M | 10% | Dec 2025 |
|
| BVF | 2.2M | $7.6M | 100% | Sep 2025 |
|
| Samsara BioCapital | 2.0M | $7.8M | 100% | Dec 2025 |
|
| Siren | 1.5M | $6.0M | 100% | Dec 2025 |
|
| BlackRock | 1.2M | $4.9M | 1881% | Dec 2025 |
|
| Woodline Partners | 1.0M | $4.0M | 100% | Dec 2025 |
|
| Geode Capital Management | 940k | $3.8M | 1081% | Dec 2025 |
|
| Kingdon Capital Management | 933k | $3.2M | 300% | Sep 2025 |
|
| Stempoint Capital | 899k | $3.6M | 62% | Dec 2025 |
|
| Goldman Sachs Group | 832k | $3.3M | 100% | Dec 2025 |
|
| Point72 Asset Management | 808k | $3.2M | 3630% | Dec 2025 |
|
| Stonepine Capital Management | 594k | $2.4M | -44% | Dec 2025 |
|
| Silverarc Capital Management | 357k | $1.4M | 100% | Dec 2025 |
|
| State Street Corporation | 198k | $793k | 412% | Dec 2025 |
|
| Northern Trust | 178k | $713k | 100% | Dec 2025 |
|
| Pale Fire Capital SE | 168k | $670k | -7% | Dec 2025 |
|
| Susquehanna International | 150k | $600k | 17% | Dec 2025 |
|
| Affinity Asset Advisors | 145k | $580k | 100% | Dec 2025 |
|
| Palumbo Wealth Management | 113k | $453k | 19% | Dec 2025 |
|
| OMERS Administration Corporation | 109k | $437k | 100% | Dec 2025 |
|
| Jane Street | 91k | $366k | 100% | Dec 2025 |
|
| Marshall Wace | 81k | $322k | 100% | Dec 2025 |
|
| ExodusPoint Capital Management | 79k | $316k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 68k | $271k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 67k | $267k | 100% | Dec 2025 |
|
| Millennium Management | 65k | $222k | -17% | Sep 2025 |
|
| Barclays | 58k | $230k | 100% | Dec 2025 |
|
| Susquehanna Portfolio Strategies | 43k | $173k | 100% | Dec 2025 |
|
| Hudson Bay Capital Management | 32k | $129k | 100% | Dec 2025 |
|
| Leucadia National Corporation | 26k | $105k | 100% | Dec 2025 |
|
| Man Group | 24k | $97k | 100% | Dec 2025 |
|
| Virtu Financial | 23k | $90k | 100% | Dec 2025 |
|
| Lighthouse Investment Partners | 22k | $89k | 100% | Dec 2025 |
|
| Stifel Financial | 21k | $82k | 100% | Dec 2025 |
|
| Creative Planning | 16k | $66k | 100% | Dec 2025 |
|
| Caxton | 16k | $62k | 100% | Dec 2025 |
|
| Two Sigma Investments | 14k | $47k | 100% | Sep 2025 |
|
| Squarepoint Ops | 13k | $50k | 100% | Dec 2025 |
|
| Tower Research Capital | 10k | $42k | -2% | Dec 2025 |
|
| UBS Group | 4.1k | $17k | -97% | Dec 2025 |
|
| Group One Trading | 4.0k | $16k | 0% | Dec 2025 |
|
| Point72 Asia | 2.9k | $10k | 100% | Sep 2025 |
|
| Signature | 2.8k | $11k | 100% | Dec 2025 |
|
| Royal Bank of Canada | 2.5k | $15k | -18% | Sep 2025 |
|
| Atlantic Trust | 2.2k | $8.7k | 0% | Dec 2025 |
|
| Pnc Financial Services | 1.8k | $7.0k | 0% | Dec 2025 |
|
| Russell Investments | 729.00 | $2.9k | 0% | Dec 2025 |
|
| Hanson McClain Advisors | 715.00 | $2.9k | 100% | Dec 2025 |
|
| Bleichroeder | 595.00 | $2.4k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 511.00 | $2.0k | -8% | Dec 2025 |
|
| Farther Finance Advisors | 331.00 | $1.3k | 100% | Dec 2025 |
|
| Ronald Blue Trust | 284.00 | $1.1k | 0% | Dec 2025 |
|
| Fortitude Family Office | 137.00 | $548.000000 | 100% | Dec 2025 |
|
| SBI Securities | 50.00 | $200.000000 | -77% | Dec 2025 |
|
| Jones Financial Companies, L.L | 38.00 | $131.001200 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 33.00 | $112.998600 | 100% | Sep 2025 |
|
| Goss Wealth Management | 33.00 | $132.000000 | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 33.00 | $132.000000 | 0% | Dec 2025 |
|
| HighMark Wealth Management | 6.00 | $24.000000 | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 5.00 | $20.000000 | 100% | Dec 2025 |
|
Who sold out of X4 Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boothbay Fund Management | Sep 2025 | 344k | $1.2M |
| UBS O'Connor | Jun 2025 | 80k | $152k |
| AQR Capital Management | Jun 2025 | 26k | $50k |
| Renaissance Technologies | Sep 2025 | 19k | $66k |
| FMR | Jun 2025 | 1.7k | $3.2k |
| TD Waterhouse Canada | Sep 2025 | 1.5k | $5.4k |